Health
Could heparin-based therapies be a viable treatment for COVID-19? – The Science Board
Researchers have identified a novel approach to treating SARS-CoV-2 infection, spurred by a new understanding of viral attachment involving a heparan sulfate, a common glycoprotein. The results are presented in a September 14 article published in Cell
Some viruses interact with heparan sulfate, a highly negatively charged linear polysaccharide that is attached to a small set of membrane or extracellular matrix proteoglycans. In this format, glycan-binding domains on membrane proteins facilitate initial attachment of virions to glycan receptors, leading to eventual virus engulfment and internalization.
Trimeric spike proteins of SARS-CoV-2 engage human angiotensin-converting enzyme 2 (ACE2) with one or more receptor binding domains (RBD) in t…
-
General18 hours agoIran’s currency at record low as tensions run high
-
Noosa News24 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News22 hours agoHundreds pack neighbourhood for no-reserve auction of ready-made charity home
-
General11 hours agoTexas opens probe into Kellogg’s health claims, dyes